Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print

Financial Reports

Related Searches:

Filter by:

Financial Report: Astra Zeneca 3Q
October 25, 2012
Seroquel IR losses account for big drop in revenues   Read More »
Financial Report: Sanofi 3Q
October 25, 2012
Genzyme revenues staunch patent losses   Read More »
Financial Report: BMS 3Q
October 24, 2012
Patent expiries demolish revenues, Ph III cancellation pummels earnings   Read More »
Financial Report: Lilly 3Q
October 24, 2012
Revenues down 11% in the quarter, post-Zyprexa   Read More »
Financial Report: Alexion 3Q
October 24, 2012
Revenues up 44% in the quarter   Read More »
Financial Report: Gilead 3Q
October 24, 2012
Antiviral product sales up 13%   Read More »
Financial Reports: Abbott 3Q12
October 17, 2012
Humira revenues dip as foreign currencies slide   Read More »
Financial Reports: J&J 3Q12
October 16, 2012
Currency rates, device charges tamp down results   Read More »
Financial Report: Patheon
September 13, 2012
Revenues up 18% in the quarter   Read More »
Financial Report: BASi
August 14, 2012
Restructuring charges impact results   Read More »
Financial Report: WuXi PharmaTech
August 14, 2012
Revenues up 29% in the quarter   Read More »
Financial Report: Novo Nordisk
August 9, 2012
Revenues up 17% in first half   Read More »
Financial Report: PAREXEL
August 9, 2012
Revenues up 26% in the quarter   Read More »
Financial Report: Charles River Laboratories
August 8, 2012
Foreign exchange impacts sales   Read More »
Financial Report: BioClinica
August 8, 2012
Revenues up 13% in the quarter   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: